Ashfield Capital Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-25,254
| Closed | -$1.28M | – | 252 |
|
|
2017
Q3 | $1.28M | Sell |
25,254
-1,709
| -6% | -$86.8K | 0.17% | 124 |
|
|
2017
Q2 | $1.45M | Sell |
26,963
-1,449
| -5% | -$78.1K | 0.2% | 116 |
|
|
2017
Q1 | $1.5M | Buy |
28,412
+2,062
| +8% | +$109K | 0.21% | 114 |
|
|
2016
Q4 | $1.27M | Sell |
26,350
-2,536
| -9% | -$122K | 0.12% | 129 |
|
|
2016
Q3 | $1.56M | Buy |
28,886
+16,928
| +142% | +$912K | 0.13% | 120 |
|
|
2016
Q2 | $648K | Buy |
11,958
+1,596
| +15% | +$86.5K | 0.05% | 175 |
|
|
2016
Q1 | $525K | Sell |
10,362
-1,716
| -14% | -$86.9K | 0.04% | 185 |
|
|
2015
Q4 | $609K | Sell |
12,078
-5,408
| -31% | -$273K | 0.04% | 187 |
|
|
2015
Q3 | $840K | Sell |
17,486
-1,522
| -8% | -$73.1K | 0.05% | 170 |
|
|
2015
Q2 | $990K | Sell |
19,008
-857
| -4% | -$44.6K | 0.05% | 164 |
|
|
2015
Q1 | $1.15M | Buy |
19,865
+1,671
| +9% | +$96.4K | 0.06% | 154 |
|
|
2014
Q4 | $972K | Buy |
18,194
+5,040
| +38% | +$269K | 0.05% | 167 |
|
|
2014
Q3 | $756K | Buy |
13,154
+622
| +5% | +$35.7K | 0.04% | 189 |
|
|
2014
Q2 | $838K | Buy |
12,532
+2,148
| +21% | +$144K | 0.04% | 176 |
|
|
2014
Q1 | $694K | Hold |
10,384
| – | – | 0.03% | 181 |
|
|
2013
Q4 | $693K | Buy |
10,384
+800
| +8% | +$53.4K | 0.03% | 179 |
|
|
2013
Q3 | $601K | Buy |
9,584
+1,691
| +21% | +$106K | 0.03% | 183 |
|
|
2013
Q2 | $493K | Buy |
+7,893
| New | +$493K | 0.03% | 184 |
|